Showing results (1-10 of 1,845) with videos related to
Sort By:
Pageof 185
Statistics in Medicine|September 20, 2016
Optimal sequential enrichment designs for phase II clinical trialsYong Zang, Ying YuanGenetic Epidemiology|August 13, 2013
A shrinkage method for testing the Hardy-Weinberg equilibrium in case-control studiesYong Zang, Ying YuanBiostatistics (Oxford, England)|March 9, 2016
Optimal marker-strategy clinical trial design to detect predictive markers for targeted therapyYong Zang, Suyu Liu, Ying YuanBiometrics|February 16, 2024
A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparisonYong Zang, Peter F Thall, Ying YuanClinical Trials (London, England)|May 22, 2014
Adaptive designs for identifying optimal biological dose for molecularly targeted agentsYong Zang, J Jack Lee, Ying YuanPharmaceutical Statistics|April 11, 2023
Generalized phase I-II designs to increase long term therapeutic success ratePeter F Thall, Yong Zang, Ying YuanBiometrics|July 24, 2025
Precision generalized phase I-II designsSaijun Zhao, Peter F Thall, Ying Yuan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Novel Clinical Trial Designs with Dose Optimization to Improve Long-term OutcomesPeter F Thall, Yong Zang, Andrew G Chapple, et al.Statistics in Medicine|August 28, 2020
BILITE: A Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacyBeibei Guo, Yong ZangStatistical Methods in Medical Research|February 22, 2022
A Bayesian phase I/II biomarker-based design for identifying subgroup-specific optimal dose for immunotherapyBeibei Guo, Yong ZangPageof 185